
Keywords: اتنزامید; pharmaceutical co-crystal; co-crystal; crystal engineering; hygroscopicity; stability; solubility; API; active pharmaceutical ingredient; CNB; 2-chloro-4-nitrobenzoic acid; DSC; differential scanning calorimetry; ETZ; ethenzamide; FFA; flufenamic acid; NM